|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis显示文摘AIM To confirm previous conclusions on Saccharomyces cerevisiae(S. cerevisiae) CNCM I-3856 for irritable bowel syndrome(IBS) management.METHODS An individual patient data meta-analysis was performed on two randomized clinical trials studying the effect of S. cerevisiae CNCM I-3856 supplementation on gastrointestinal(GI) symptoms in IBS subjects. A total of 579 IBS subjects were included. Outcomes were the daily Likert scale scores of abdominal pain/discomfort and bloating [area under the curve(AUC) and weekly means], responder status, and bowel movements(stool frequency and consistency). Statistical analyses were conducted in Intent to Treat(ITT) population, IBS-C subjects and IBS-C subjects with an abdominal pain/discomfort score higher than or equal to 2 at baseline('IBS-C ≥ 2 subpopulation').RESULTS S. cerevisiae CNCM I-3856 significantly improved abdominal pain/discomfort and bloating during the second month of supplementation [AUC(W5-W8)]with improvement up to the minimal clinically relevant threshold of 10%: a 12.3% reduction of abdominal pain/discomfort in the ITT population compared to the Placebo group(P = 0.0134) has been observed. In the IBS-C ≥ 2 subpopulation, there were a 13.1% reduction of abdominal pain/discomfort and a 14.9% reduction of bloating compared to the Placebo group(P = 0.0194 and P = 0.0145, respectively). GI symptoms significantly decreased during supplementation but no statistical differences were reported between groups at the end of the supplementation period. Responder status was defined as a subject who experienced a decrease of 1 arbitrary unit(a.u.) or 50% of the abdominal discomfort score from baseline for at least 2 wk out of the last 4 wk of the study. A significant difference between groups was reported in the ITT population, when considering the first definition: subjects in the Active group had 1.510 higher odds to be a responder(reduction of 1 a.u. of abdominal pain/discomfort) compared with subjects in the Placebo group(P = 0.0240). At the end of supplementation period, stool consistency in the Active group of the ITT population was significantly improved and classified as 'normal' compared to Placebo(respectively 3.13 ± 1.197 a.u. vs 2.58 ± 1.020 a.u., P = 0.0003). Similar results were seen in the IBS-C ≥ 2 subpopulation(Active group: 3.14 ± 1.219 a.u. vs Placebo group: 2.59 ± 1.017 a.u., P = 0.0009).CONCLUSION This meta-analysis supports previous data linking S. cerevisiae I-3856 and improvement of GI symptoms, in IBS overall population and in the IBS-C and IBS-C ≥ 2 subpopulations. | Amélie Cayzeele-Decherf Fanny Pélerin Sébastien Leuillet Benoit Douillard Béatrice Housez Murielle Cazaubiel Gunnard K Jacobson Peter Jüsten Pierre Desreumaux | 2017 | World Journal of Gastroenterology2017，23，2： | 2 |
| 2 | Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α显示文摘 | Marie Lagouge Carmen Argmann Zachary Gerhart-Hines Hamid Meziane Carles Lerin Frederic Daussin Nadia Messadeq Jill Milne Philip Lambert Peter Elliott Bernard Geny Markku Laakso Pere Puigserver Johan Auwerx | 2006 | Cell2006，，6： | 2 |
| 3 | Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α显示文摘 | Marie Lagouge Carmen Argmann Zachary Gerhart-Hines Hamid Meziane Carles Lerin Frederic Daussin Nadia Messadeq Jill Milne Philip Lambert Peter Elliott Bernard Geny Markku Laakso Pere Puigserver Johan Auwerx | 2006 | Cell2006，，6： | 2 |
| 4 | Metabolic adaptations through the PGC-1α and SIRT1 pathways显示文摘 | RODGERS J T LERIN C GERHART-HINES Z | 2008 | FEBS Letters2008，582，1： | 1 |
| 5 | large trials vs meta-analysis of smaller trials显示文摘 | Klebanoff Ma Lerine RJ Dersimonian R | 1997 | JAMA1997，277，： | 1 |
| 6 | Resveratrol improves health and survival of mice on a high-calorie diet显示文摘 | Baur JA Pearson KJ Price NL Jamieson HA Lerin C Kalra A | 2006 | Nature2006，444，： | 1 |
| 7 | Metabolic adaptations through the PGC - 1 alpha and SIRT1 pathways 显示文摘 | Rodgers JT Lerin C Gerhart - Hines Z | 2008 | FEBS Lett2008，582，1： | 1 |
| 8 | Vegetative state after closed-head injury-atrumatic coma date bata bank显示文摘 | Lerin HS Saydijaric Eisengerg HM | 1991 | Veport Arch Neurol1991，48，： | 1 |
| 9 | Microorganismsscreening for limonene oxidation显示文摘 | Lindomar LERIN’Geciane TONIAZZO | 2010 | Food Science andTechnology2010，30，2： | 1 |
| 10 | GCN5-mediated transcriptional control of the metabolic coactivator PGC-1β through lysine acetylation 显示文摘 | Kelly T J Lerin C Haas W | 2009 | J Biol Chem2009，284，30： | 1 |
| 11 | Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1显示文摘 | Rodgers JT Lerin C Haas W | 2005 | Nature2005，434，7029： | 1 |
| 12 | Intranasal endoscopic analysis of dacryocystorhinostomy failure 显示文摘 | Allen KM Berlin A J Lerine HL | 1988 | Ophthalmic Plast Reconstr Surg1988，4，1： | 1 |
| 13 | Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1显示文摘 | Rodgers JT Lerin C Haas W | 2005 | Nature2005，434，7029： | 1 |
| 14 | Value of barium studies for predicting primary versus secondary non-Hogkin's gastrointestinal jymphoma显示文摘 | Foo CC Lerine MS Mclarney JK | 2000 | Abdam Imaging2000，25，4： | 1 |
| 15 | Relombinant bactericidel premeability-inereasing protein(rBPI21)as adiunctire freatment for children with serere meningcococal sepsis:a randomised tria显示文摘 | Quint P A Goldstein B | 2000 | Lancent2000，356，9234： | 1 |
| 16 | Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1显示文摘 | RODGERS J T LERIN C HAAS W | 2005 | Nature2005，434，7029： | 1 |
| 17 | The P53 tumor suppressor gene显示文摘 | Lerine AJ Momand J Finlay CA | 1991 | Nature1991，351，： | 1 |
| 18 | Nutrient control of glucosehomeostasis through a complex of PGC-1 alpha and SIRT1 显示文摘 | Rodgers JT Lerin C Haas W | 2005 | Nature2005，434，： | 1 |
| 19 | Eisenberg HM Vegetative state after closed-heodinjury-atrumatie coma date bata bank显示文摘 | Saydjari C | 1991 | Veport Arch Neuro1991，48，： | 1 |
| 20 | Metabolic adaptations through the PGC- 1 alpha and SIRT1 pathways 显示文摘 | Rodgers JT Lerin C Gerhart-Hines Z | 2008 | FEBS Lett2008，582，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员